<DOC>
	<DOCNO>NCT02414542</DOCNO>
	<brief_summary>Post-marketing clinical study , international , multi-centre , prospective , observational . The investigation carry 2 site Europe maximum total number 160 patients.The aim study assess clinical , radiographic subjective outcome hip arthroplasty cementless metaphyseal MINIMA short stem , define survivorship implant identify possible risk factor may lead failure .</brief_summary>
	<brief_title>Minima Clinical Study</brief_title>
	<detailed_description />
	<criteria>1 . Both gender 2 . Age â‰¥ 18 year old 3 . Life expectancy 5 year 4 . Any race 5 . Ambulatory patient 6 . Painful primary coxarthrosis 7 . Painful secondary coxarthrosis 8 . Avascular necrosis 9 . Willingness comply rehabilitation study evaluation ability return followup visit 10 . Signed studyspecific Informed Consent Form 1 . Body mass index 28 kg/m2 modular version 2 . Requiring revision previous standard femoral stem 3 . Symptomatic OA knee , spine , ankles contralateral hip , interfere evaluation target hip accord Investigator 4 . Previous hip replacement ( resurface THR ) contralateral side whose outcome achieve HHS &lt; 60 point 5 . Significant proven suspicious infection target hip 6 . Any serious infectious disease study accord Investigator 7 . Muscular insufficiency may compromise functional recovery 8 . Proven osteopenia osteoporosis severe enough compromise stem support accord Investigator 9 . Known suspicious hypersensitivity metal implant 10 . Recurrent medical history immunemediated reaction systemic immune disorder 11 . Vascular insufficiency peripheral neuropathy low limb severe enough interfere study evaluation accord Investigator 12 . Current treatment treatment malignancy within previous 2 year preoperative visit 13 . Previous organ transplant 14 . Any intercurrent chronic disease condition may interfere completion 60month followup , liver disease , severe coronary disease , clinically significant condition Investigator feel may affect study evaluation 15 . Known coexistent medical condition death anticipate within five year due preexist medical condition 16 . Any clinically significant find would place patient health risk , impact study , affect completion study 17 . Current alcoholism , and/or know current addiction pain medication drug 18 . Any psychiatric illness would prevent comprehension detail nature study 19 . Participation experimental drug/device study within 6 month prior preoperative visit 20 . Unwillingness inability comply rehabilitation return followup visit 21 . Women childbearing potential pregnant , nursing , plan become pregnant , agree remain acceptable method birth control throughout entire study period</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>